Conduit Pharmaceuticals Inc. appointed Simon Fry as a director effective December 18, 2024, and amended James Bligh's employment agreement to include a $400,000 salary and a potential 40% bonus; they also amended their bylaws to change quorum requirements for stockholder meetings.